Roivios is a clinical-stage medical device company that aims to reduce or eliminate acute kidney injury (AKI) by providing a first-to-market solution to address the underlying causes of cardiac surgery associated-acute kidney injury (CSA-AKI).
Roivios is a medical device company pioneering a novel renal assist device designed to reduce or eliminate acute kidney injury (AKI) in patients who are at elevated risk. The company believes that complex, expensive medical problems require effective solutions and few problems are as large and complex as kidney disease.
Roivios has competitors in the medical device industry such as NxStage Medical Inc., Fresenius Medical Care AG & Co. KGaA, and B. Braun Melsungen AG.
Roivios is a medical device company pioneering a novel renal assist device designed to reduce or eliminate acute kidney injury (AKI) in patients who are at elevated risk. The company believes that complex, expensive medical problems require effective solutions and few problems are as large and complex as kidney disease.
Roivios has competitors in the medical device industry such as NxStage Medical Inc., Fresenius Medical Care AG & Co. KGaA, and B. Braun Melsungen AG.
Location: Bahamas, New Providence
Employees: 1-10
Founded date: 2021
Mentions in press and media 1
| Date | Title | Description |
| 26.04.2024 | Roivios Secures FDA Breakthrough Device Designation for JuxtaFlow® RAD, Showcases Pioneering Data at Society of Cardiovascular Anesthesiologists Annual Meeting | NASSAU, Bahamas, April 26, 2024 /PRNewswire/ -- Roivios, a pioneering clinical-stage medical device company dedicated to transforming kidney health, is thrilled to announce it has been awarded the prestigious Breakthrough Device Designation... |